All kinds of pharmaceutical services.
A meeting was held with the Mission led by Olga Avdeyeva, project manager for Eastern Europe and Central Asia of the Global Fund, in the Ministry of Health of Azerbaijan. Greeting the guests, Minister of Health Teymur Musayev noted that Azerbaijan h...
See more
The Local Production and Assistance Unit (LPA), under the Regulation and Prequalification (RPQ) Department, and Access to Medicines and Health Products (MHP) Division of WHO, has finalized the establishment of the Technical Advisory Group on Loc...
See more
Countries of the World Health Organization have begun negotiations on a global accord on pandemic prevention, preparedness and response, using the “zero draft” as a basis for negotiating an agreement to protect nations and communities from future pan...
See more
Governments agreed on a way forward for updating the WHO International Health Regulations 2005 (IHR), holding the first round of intensive discussions on more than 300 amendments proposed by countries to this globally agreed instrument. The IHR ...
See more
Almirall, S.A. (ALM), a global biopharmaceutical company focused on skin health, launched its 7th call through AlmirallShare, its open innovation platform, for proposals to establish collaborations in dermatological research. The aim of this year'...
See more
Idorsia Ltd announced that the European Commission (EC) has granted marketing authorisation for QUVIVIQ (daridorexant) for the treatment of adult patients with insomnia characterised by symptoms present for at least three months and considerable impa...
See more
The proportion of pharmaceutical companies hiring for machine learning related positions rose in June 2022 compared with the equivalent month last year, with 26.4% of the companies included in our analysis recruiting for at least one such position. ...
See more
In a recent interview, Rebecca Gomperts, MD, founder of Aid Access, highlighted plans to make abortion pills available as a weekly contraceptive. In an interview with Democracy Now, Rebecca Gomperts, MD, mentioned plans to make mifepristone, the a...
See more
Two newer omicron subvariants, BA.4 and BA.5, are both increasing in our community. "These variants ebb and flow across the country. Now it's our turn to be dealing with BA.4 and BA.5 as the situation evolves. We should anticipate the emergence o...
See more
Six weeks after Clovis voluntarily discontinued its third-line use of ovarian cancer drug Rubraca in the United States for safety reasons, Europe’s Committee for Medicinal Products for Human Use has concurred with the action. The CHMP recommends t...
See more
Azərbaycanca 
Русский 